Nutex Health, Inc. Quarterly Debt-to-equity in % from Q1 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nutex Health, Inc. quarterly Debt-to-equity history and growth rate from Q1 2018 to Q3 2024.
  • Nutex Health, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 542 %, a 50.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 542 +182 +50.7% Sep 30, 2024
Q2 2024 490 +168 +52.1% Jun 30, 2024
Q1 2024 438 +288 +192% Mar 31, 2024
Q4 2023 399 Dec 31, 2023
Q3 2023 360 Sep 30, 2023
Q2 2023 322 Jun 30, 2023
Q1 2023 150 Mar 31, 2023
Q1 2021 22.4 -70.2 -75.8% Mar 31, 2021
Q4 2020 120 +64.6 +116% Dec 31, 2020
Q3 2020 120 +72.1 +151% Sep 30, 2020
Q2 2020 132 +74.4 +129% Jun 30, 2020
Q1 2020 92.6 Mar 31, 2020
Q4 2019 55.8 Dec 31, 2019
Q3 2019 47.7 Sep 30, 2019
Q2 2019 57.6 Jun 30, 2019
Q1 2018 25.5 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.